Yu‐Ning Wong - Concepedia

Author

Yu‐Ning Wong

Fox Chase Cancer Center

Also Known As

Akhila Wimalasingham, Chen, Ronald C., Sridhar, Srikala S., Yu-Ning Wong, Yu‐Ning Wong

187

Publications

7.1K

Citations

H-Index

103

Concepts

All Affiliations

Fox Chase Cancer Center Dana-Farber Cancer Institute Temple University Health System University of Pennsylvania City of Hope

About

Yu‐Ning Wong is an author at Fox Chase Cancer Center specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	27	1K
2	Health Sciences	9	9	348
3	Public Health	6	6	206
4	Management	1	1	54
5	Nursing	1	1	53

Yu‐Ning Wong

Publications

6.8K

Citations

H-Index

Page 1

	Year	Citations
Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work Steven R. Austin, Yu‐Ning Wong, Robert G. Uzzo, Medical Care	2013	682
Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer Network Nancy U. Lin, Ann Vanderplas, Melissa E. Hughes, Cancer	2012	679
Time to Surgery and Breast Cancer Survival in the United States Richard J. Bleicher, Karen Ruth, Elin R. Sigurdson, JAMA Oncology	2015	594
Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival Ann H. Partridge, Melissa E. Hughes, Erica T. Warner, Journal of Clinical Oncology	2016	444
Evaluating Overall Survival and Competing Risks of Death in Patients With Localized Renal Cell Carcinoma Using a Comprehensive Nomogram Alexander Kutikov, Brian L. Egleston, Yu‐Ning Wong, Journal of Clinical Oncology	2009	293
Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors Erica T. Warner, Rulla M. Tamimi, Melissa E. Hughes, Journal of Clinical Oncology	2015	284
Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle‐invasive bladder cancer Matthew D. Galsky, Sumanta K. Pal, Simon Chowdhury, Cancer	2015	194
Impact on overall survival (OS) with chemohormonal therapy versus hormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa): An ECOG-led phase III randomized trial. Christopher J. Sweeney, Yu‐Hui Chen, Michael A. Carducci, Journal of Clinical Oncology Metastatic PrcaLba2 BackgroundPharmacotherapyOverall SurvivalOncology	2014	188
Preoperative Delays in the US Medicare Population With Breast Cancer Richard J. Bleicher, Karen Ruth, Elin R. Sigurdson, Journal of Clinical Oncology	2012	146
Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer care Karyn B. Stitzenberg, Yu‐Ning Wong, Matthew E. Nielsen, Cancer	2011	139

Page 1